Granules India receives a form 483 from the FDA with 11 observations during inspection, highlighting process and documentation improvements needed at their Gagillapur facility. No data integrity or ...
A Delhi court discharges former Joint Drugs Controller Dr. S. Eswara Reddy and three others in a bribery case involving ...
Gilead Sciences increases its 2026 sales outlook to $31-$31.3 billion while announcing a 38% price reduction for Biktarvy ...
AstraZeneca reveals a strategic plan to save $1.5 billion annually for investment in its drug pipeline, signaling a ...
Bengaluru: Karnataka Health Minister Dinesh Gundu Rao on Thursday launched a monitoring portal for the detection of NSQ drugs and the prevention of misuse of NDPS, aimed at strengthening surveillance, ...
Sun Pharmaceutical Industries has received regulatory approval to manufacture and market its generic semaglutide pill in ...
Inovio Pharmaceuticals has received FDA approval for Voceryq, a groundbreaking treatment for recurrent respiratory ...
In the September quarter, India's pharma sector experienced a decline in M&A deal value and volume while private equity ...
The Union Health Ministry of India has revised the shelf life requirements for imported drugs, adjusting from 60% to a ...
Eli Lilly raises revenue outlook for the year due to skyrocketing sales of weight-loss drugs, while adjusting profit ...
Sun Pharma reports flat sequential growth in innovative medicines despite year-on-year increase, as Ilumya faces execution ...
The Indian Patent Office has rejected a patent application for the BPaL regimen, a groundbreaking treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results